SoftWave Therapy for Knee Pain: What to Expect Before, During, and After Treatment

Knee pain has a way of shrinking your world. Stairs become a calculation. Walks get shorter. Eventually, you stop signing up for the things you used to enjoy. If you have already tried physical therapy, anti-inflammatories, or cortisone injections without lasting relief, you have probably started looking at less conventional options. SoftWave therapy is one of those options, and the questions most patients ask are reasonable ones: does it actually work, what does it feel like, and how long until I know if it helped? This guide walks through what happens at each stage of treatment so you can decide whether SoftWave fits your situation.

SoftWave is a non-invasive technology that delivers unfocused acoustic shockwaves to soft tissue and joint structures. The waves penetrate up to 3 inches and trigger a biological response in the target area, including increased blood flow, recruitment of stem cells, and reduced inflammation in surrounding tissue.
Unlike focused shockwave devices that concentrate energy at a single point, SoftWave’s unfocused beam covers a broader treatment area, which is one reason it is often used for diffuse pain patterns common in knee conditions. The technology was cleared by the FDA for the activation of connective tissue and the treatment of certain musculoskeletal conditions, and it is currently used by chiropractors, physical therapists, and sports medicine providers across the United States.
For a deeper technical breakdown, see our complete guide on how SoftWave therapy works.

Most patients who book a SoftWave consultation have already exhausted conservative options. They have tried rest, physical therapy, NSAIDs, sometimes injections, and the pain has either returned or never fully resolved. The appeal of SoftWave is that it sits between conservative care and surgery, with no incisions, no downtime, and no drugs.
A 2022 systematic review published in the Journal of Orthopaedic Surgery and Research found that extracorporeal shockwave therapy produced statistically significant pain reduction in patients with knee osteoarthritis compared to control groups, though the authors noted that the magnitude of benefit varies by protocol and patient factors. SoftWave is one of several shockwave technologies used in this category.
This does not mean it works for everyone. The candidates who tend to respond well share a few traits: their pain is mechanical rather than purely neurological, the underlying tissue still has regenerative capacity, and they commit to the full series rather than stopping after one or two sessions.

The knee is a common SoftWave target because it contains the kinds of tissue the technology was designed to influence: tendons, ligaments, cartilage interfaces, and chronically inflamed soft tissue. Conditions that providers commonly evaluate for SoftWave include:

• Mild to moderate knee osteoarthritis
• Patellar tendonitis (jumper’s knee)
• Quadriceps tendinopathy
• IT band syndrome at the lateral knee
• Chronic soft-tissue inflammation following injury
• Post-surgical scar tissue and adhesions

SoftWave is not appropriate for every knee condition. Acute fractures, active infections, deep vein thrombosis, and certain tumors are contraindications. A proper evaluation determines whether you are a candidate.

Preparation matters because the first appointment doubles as a diagnostic visit. The provider needs to understand the source of your pain before recommending a treatment plan, and the more information you bring, the more useful that conversation becomes.
Bring imaging if you have it (X-rays, MRIs, ultrasound reports), a written list of medications and supplements, and a brief timeline of when the pain started, what made it worse, and what you have already tried. Wear loose pants or shorts that allow access to the knee. Avoid taking anti-inflammatory medications on the day of treatment, since they can blunt the inflammatory response that SoftWave is trying to trigger.

Three patterns predict poor outcomes more than any clinical factor.
The first is stopping early. Patients who feel some improvement after three sessions and skip the remaining ones often regress within weeks. The protocol is designed as a series for a reason.
The second is masking the response. Taking NSAIDs, icing aggressively, or stacking unrelated treatments during the series can interfere with the biological cascade SoftWave initiates.
The third is underestimating load management. SoftWave stimulates repair, but if you keep loading the knee with the same volume that caused the problem, you are working against your own treatment.

Some knee symptoms should not wait for an elective treatment evaluation. Seek immediate medical attention if you experience:

• Sudden severe knee pain after a fall or impact
• Visible deformity or inability to bear weight
• Significant swelling that develops rapidly within hours
• Fever combined with knee redness or warmth (possible infection)
• Calf pain or swelling alongside knee symptoms (rule out blood clot)
• Numbness, tingling, or weakness in the leg or foot

These signs may indicate a fracture, infection, deep vein thrombosis, or nerve injury, and they require urgent evaluation rather than a SoftWave consultation.